AngioDynamics (ANGO) SVP reports 3,838-share tax withholding event

Rhea-AI Filing Summary

AngioDynamics Inc. executive Chad Thomas Campbell, SVP/GM Vascular Access, reported tax-related dispositions totaling 3,838 shares of common stock. On July 16, 17, and 20, 2026, shares were withheld at $14.14, $13.51, and $13.71 per share to satisfy tax withholding obligations from pre-determined vesting of restricted stock units granted in 2025, 2024, and 2022.

Insider Trade Summary

Net Seller: 3,838 shares

Net Sell 3 txns

Insider Campbell Chad Thomas

Role SVP/GM, Vascular Access

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F3	359	$13.71	$5K
Tax Withholding	Common Stock F2	1,112	$13.51	$15K
Tax Withholding	Common Stock F1	2,367	$14.14	$33K

Holdings After Transaction: Common Stock — 88,459 shares (Direct)

Footnotes (3)

1. F1. The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
2. F2. The exempt disposition of 1,112 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
3. F3. The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

Key Figures

Shares withheld for taxes: 3,838 shares Shares on 2026-07-16: 2,367 shares Shares on 2026-07-17: 1,112 shares +1 more

4 metrics

Shares withheld for taxes 3,838 shares Total common shares used to satisfy tax withholding on RSU vesting

Shares on 2026-07-16 2,367 shares Exempt disposition to satisfy tax withholding on RSUs granted July 16, 2025

Shares on 2026-07-17 1,112 shares Exempt disposition to satisfy tax withholding on RSUs granted July 17, 2024

Shares on 2026-07-20 359 shares Exempt disposition to satisfy tax withholding on RSUs granted July 20, 2022

Key Terms

exempt disposition, tax withholding obligations, restricted stock units, pre-determined vesting

4 terms

exempt disposition financial

"The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc."

tax withholding obligations financial

"was made to satisfy tax withholding obligations in connection with the pre-determined vesting"

restricted stock units financial

"vesting of shares underlying restricted stock units granted to the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

pre-determined vesting financial

"in connection with the pre-determined vesting of shares underlying restricted stock units"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/21/2026 - 08:11 PM Accepted by SEC EDGAR 07/21/2026 - 08:10 PM Learn about SEC filing dates

FAQ

What insider activity did AngioDynamics (ANGO) executive Chad Thomas Campbell report?

Chad Thomas Campbell reported tax-related share dispositions rather than open-market sales. In three transactions, AngioDynamics common shares were withheld to cover tax obligations tied to the vesting of previously granted restricted stock units on specified grant dates.

How many ANGO shares were used to satisfy Chad Thomas Campbell’s tax withholding?

A total of 3,838 AngioDynamics shares were used to satisfy Campbell’s tax withholding obligations. These consisted of 2,367, 1,112, and 359 shares related to separate restricted stock unit vestings occurring on different grant schedules.

Were Campbell’s ANGO transactions open-market stock sales?

No, the transactions were exempt dispositions for tax withholding, not open-market sales. Shares were delivered or withheld by AngioDynamics to pay tax liabilities arising from the pre-determined vesting of restricted stock units previously granted to Campbell.

On what dates and at what prices were ANGO shares withheld for Campbell’s taxes?

Shares were withheld on July 16, 17, and 20, 2026 at $14.14, $13.51, and $13.71 per share. Each date corresponds to tax withholding tied to separate restricted stock unit vestings from earlier grant years.

What events triggered the ANGO share withholdings for Chad Thomas Campbell?

The withholdings were triggered by the pre-determined vesting of restricted stock units. These RSUs had been granted to Campbell on July 16, 2025, July 17, 2024, and July 20, 2022, with shares used solely to cover tax obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Campbell Chad Thomas

(Last) (First) (Middle)

14 PLAZA DRIVE

(Street)

LATHAM NEW YORK 12110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP/GM, Vascular Access

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		F		2,367(1)	D	$14.14	89,930	D
Common Stock	07/17/2026		F		1,112(2)	D	$13.51	88,818	D
Common Stock	07/20/2026		F		359(3)	D	$13.71	88,459	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.

2. The exempt disposition of 1,112 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.

3. The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

	/s/ Lawrence T. Weiss, Attorney in Fact	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)